<?xml version="1.0" encoding="UTF-8"?>
<ref id="j_jtim-2019-0028_ref_011">
 <label>11</label>
 <element-citation publication-type="journal" publication-format="print">
  <name>
   <surname>Buzzigoli</surname>
   <given-names>SB</given-names>
  </name>
  <name>
   <surname>Genovesi</surname>
   <given-names>M</given-names>
  </name>
  <name>
   <surname>Lambelet</surname>
   <given-names>P</given-names>
  </name>
  <name>
   <surname>Logi</surname>
   <given-names>C</given-names>
  </name>
  <name>
   <surname>Raffaelli</surname>
   <given-names>S</given-names>
  </name>
  <name>
   <surname>Cattano</surname>
   <given-names>D</given-names>
  </name>
  <article-title>Plasmapheresis treatment in Guillain-Barre syndrome: potential benefit over intravenous immunoglobulin</article-title>
  <source>Anaesth Intensive Care</source>
  <year>2010</year>
  <volume>38</volume>
  <fpage>387</fpage>
  <lpage>9</lpage>
  <pub-id pub-id-type="pmid">20369779</pub-id>
 </element-citation>
</ref>
